PNH - paroxysmal nocturnal hemoglobinuria

Clinical trials for PNH - paroxysmal nocturnal hemoglobinuria explained in plain language.

Never miss a new study

Get alerted when new PNH - paroxysmal nocturnal hemoglobinuria trials appear

Sign up with your email to follow new studies for PNH - paroxysmal nocturnal hemoglobinuria, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for PNH: experimental drug LP-005 enters Mid-Stage trial

Disease control Ongoing

This study tests an experimental drug called LP-005 in 30 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells. The goal is to see if LP-005 can lower a key disease marker (LDH) and raise hemoglobin levels without needing bloo…

Matched conditions: PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Phase 2 • Sponsor: Longbio Pharma • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

PNH - paroxysmal nocturnal hemoglobinuria

Get alerted when new PNH - paroxysmal nocturnal hemoglobinuria trials appear

New hope for PNH: experimental drug LP-005 enters Mid-Stage trial